amfAR, The Foundation for AIDS Research

Collaborating for a Cure 

Arche image

Placing the search for a cure for HIV/AIDS firmly at the center of its research efforts, amfAR has created the amfAR Research Consortium on HIV Eradication (ARCHE). This grant program supports collaborative teams of biomedical researchers exploring strategies for eradicating HIV infection. 

“We’ve seen great strides in our collective understanding
of how HIV could potentially be eradicated.”
—amfAR CEO Kevin Robert Frost.

 "amfAR has a long and successful history of bringing people together to take on the big challenges of HIV/AIDS," says Dr. Rowena Johnston, amfAR’s vice president and director of research. "We’re tremendously excited by this consortium. And we’re confident that this collaborative approach will create a synergy that produces results that exceed what can be generated in individual laboratories."  

ARCHE Group 1
amfAR Vice President and Director of Research Dr. Rowena Johnston (fourth from left) with several recent ARCHE grantees.

ARCHE Grantees

A Gene Therapy Revolution?

New amfAR Grant Addresses Key Challenge in Cure Research

Harnessing the Power of Antibodies

Pursuit of HIV Cure Gets Funding Boost from amfAR (2014)

HIV Cure Research Gains Momentum from New amfAR Funding (2014)

Infusion of Funding for amfAR HIV Cure Consortium (2013)

Entering Third Year, amfAR Consortium Gathers Momentum in Quest for HIV/AIDS Cure (2012)

amfAR Announces Second Round of Cure-Focused Research Grants in Third Year (2012)

amfAR Consortium Helps Lead Efforts for HIV/AIDS Cure (2011)

ARCHE Research Teams and Their Projects (2010) 

  ARCHE Group 2
ARCHE grantees meet at the amfAR office to discuss their research.  

ARCHE News and Features 

amfAR Symposium Looks to Holy Grail of AIDS Research 
amfAR Ramps Up Investment in HIV Cure Research 
ARCHE Researchers Prove the Value of Collaboration 
The Search for a Cure—Why Now? 
Charting a Path to a Cure 
amfAR Consortium To Speed Search for HIV/AIDS Cure 
The Search for a Cure: An Enduring Commitment 
amfAR Launches Cure Consortium